Literature DB >> 7608132

Oligomeric structures required for complement activation of serum mannan-binding proteins.

Y Yokota1, T Arai, T Kawasaki.   

Abstract

Serum mannan-binding protein (S-MBP) comprises a series of homooligomers, and activates complement when it binds to appropriate carbohydrate ligands. In this study, the structural requirements necessary for complement activation were examined for rat, rabbit, and human S-MBPs. On SDS-PAGE under non-reducing conditions, the S-MBPs gave three major bands: large, middle, and small oligomers. Since three subunits (23-25 kDa) form a triple helix (the base structural unit) at the collagen-like domain within the S-MBP molecule, it was estimated that human and rabbit S-MBPs comprise a mixture of pentamers, tetramers, and trimers of the respective structural units. In contrast, rat S-MBP is composed of tetramers, trimers, and dimers. The large and middle oligomers were almost equal in their ability to activate complement, whereas the small oligomers had very low or no activity. Upon digestion with bacterial collagenase, the large and small oligomers were degraded almost completely. In contrast, the middle oligomers remained largely intact, and the surviving middle oligomers retained complete ability to activate complement. The degraded product, trimers of the carbohydrate recognition domain (CRD), did not show any complement activating activity. These data indicate that not only the structural integrity of the S-MBP collagen-like domain and CRD, but also a unique conformational structure present in the middle oligomers are critically important for carbohydrate-mediated complement activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608132     DOI: 10.1093/jb/117.2.414

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  14 in total

1.  The human ortholog of rhesus mannose-binding protein-A gene is an expressed pseudogene that localizes to chromosome 10.

Authors:  N Guo; T Mogues; S Weremowicz; C C Morton; K N Sastry
Journal:  Mamm Genome       Date:  1998-03       Impact factor: 2.957

Review 2.  C-type lectins with a sweet spot for Mycobacterium tuberculosis.

Authors:  G Lugo-Villarino; D Hudrisier; A Tanne; O Neyrolles
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

3.  Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement.

Authors:  Rema Rajagopalan; Takazvida Nyaundi; Veena P Salvi; Nenoo Rawal
Journal:  Mol Immunol       Date:  2010-06-25       Impact factor: 4.407

4.  Asymmetry adjacent to the collagen-like domain in rat liver mannose-binding protein.

Authors:  R Wallis; K Drickamer
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

5.  Mannan-binding lectin directly interacts with Toll-like receptor 4 and suppresses lipopolysaccharide-induced inflammatory cytokine secretion from THP-1 cells.

Authors:  Mingyong Wang; Yue Chen; Yani Zhang; Liyun Zhang; Xiao Lu; Zhengliang Chen
Journal:  Cell Mol Immunol       Date:  2011-03-07       Impact factor: 11.530

6.  Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system.

Authors:  M Cedzynski; J Szemraj; A S Swierzko; L Bak-Romaniszyn; M Banasik; K Zeman; D C Kilpatrick
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  Superoxide production from human polymorphonuclear leukocytes by human mannan-binding protein (MBP).

Authors:  Kazuhide Uemura; Harumi Yamamoto; Tomoaki Nakagawa; Kishiko Nakamura; Nobuko Kawasaki; Shogo Oka; Bruce Yong Ma; Toshisuke Kawasaki
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 8.  The lectin pathway of complement and rheumatic heart disease.

Authors:  Marcia Holsbach Beltrame; Sandra Jeremias Catarino; Isabela Goeldner; Angelica Beate Winter Boldt; Iara José de Messias-Reason
Journal:  Front Pediatr       Date:  2015-01-21       Impact factor: 3.418

Review 9.  Microglial Lectins in Health and Neurological Diseases.

Authors:  Jian Jing Siew; Yijuang Chern
Journal:  Front Mol Neurosci       Date:  2018-05-14       Impact factor: 5.639

Review 10.  Human lectins and their roles in viral infections.

Authors:  Christopher P Mason; Alexander W Tarr
Journal:  Molecules       Date:  2015-01-29       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.